Abridge

Deals

Baseten's $13 billion tranche prices a company that cuts its own rates every 15 days

Bloomberg says AI investors now split rounds into tranches so later money prints a higher price; Baseten's second tranche marked it at $13 billion in the same week it cut brand-new token prices by up to 72 percent.

October 26, 2026 · 3 min read

Health

Abridge carries a $6.69 billion mark on trials showing its scribe saves 22 minutes a day

The independent trials have landed next to the expansion metrics: 22 minutes a day is what a health system can actually count. That caps the per-encounter price and moves the value to clinical content and workflow, where Wolters Kluwer and Doximity trade.

October 22, 2026 · 2 min read

Health

Abridge launches hospital claim review, putting Athelas and parent Commure's $7 billion valuation to the test

On August 5 Commure's Athelas shipped an agentic billing suite; on September 14 Abridge, embedded in 300 health systems, launched its first claims product. The convergence puts the $7B mark Commure raised into in May up against a rival with deeper hospital distribution, and the listed middle, Waystar and Solventum, between the two.

October 9, 2026 · 3 min read

Secondary market

Latest on Abridge

Ambience's KLAS validation put $37,500 a year on each ER doctor; $6.69 billion Abridge sells minutes

Baseten's $13 billion tranche prices a company that cuts its own rates every 15 days

Abridge carries a $6.69 billion mark on trials showing its scribe saves 22 minutes a day

Abridge launches hospital claim review, putting Athelas and parent Commure's $7 billion valuation to the test

Also mentioned in

Anthropic's reported $2 trillion IPO rests on customers like Harvey, whose gross margin fell below minus 50%

Anima's AI receptionist asked a 65-year-old if she was calling about her pregnancy

$15 Billion for a Free Tool: OpenEvidence Bets Its Doctors' Reach on Hospitals and Cancer Trials